Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedJul 24, 2024
DataAggregated Company Financials
Companies50
  • 7D-1.6%
  • 3M8.7%
  • 1Y9.8%
  • YTDn/a

Over the last 7 days, the Pharma industry has remained flat, although notably Oneness Biotech gained 5.3%. The past year has been better, since the industry has gained 12% in that time. As for the next few years, earnings are expected to grow by 42% per annum.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 24 Jul 2024NT$686.2bNT$100.5bNT$6.8b32.1x100.5x6.8x
Fri, 21 Jun 2024NT$661.4bNT$100.4bNT$7.2b30.5x92.4x6.6x
Sun, 19 May 2024NT$635.2bNT$100.3bNT$8.8b28.8x72x6.3x
Tue, 16 Apr 2024NT$703.8bNT$101.5bNT$9.2b26.8x76.3x6.9x
Thu, 14 Mar 2024NT$620.5bNT$100.0bNT$8.8b24.9x70.9x6.2x
Sat, 10 Feb 2024NT$597.8bNT$101.6bNT$8.2b23.4x73.3x5.9x
Mon, 08 Jan 2024NT$581.2bNT$101.9bNT$7.8b24.2x74.6x5.7x
Wed, 06 Dec 2023NT$583.6bNT$101.6bNT$7.7b24.5x76.2x5.7x
Fri, 03 Nov 2023NT$552.0bNT$101.6bNT$9.7b22x57x5.4x
Sun, 01 Oct 2023NT$548.8bNT$101.7bNT$9.6b22x57x5.4x
Tue, 29 Aug 2023NT$532.2bNT$101.7bNT$9.6b21.7x55.3x5.2x
Thu, 27 Jul 2023NT$582.5bNT$98.7bNT$10.1b16.9x57.9x5.9x
Sat, 24 Jun 2023NT$578.4bNT$98.7bNT$10.1b17.1x57.5x5.9x
Mon, 22 May 2023NT$576.6bNT$93.8bNT$9.4b19.3x61.4x6.1x
Wed, 19 Apr 2023NT$591.4bNT$91.6bNT$8.6b22.6x69x6.5x
Fri, 17 Mar 2023NT$529.5bNT$85.5bNT$6.6b19.6x79.7x6.2x
Sun, 12 Feb 2023NT$539.9bNT$84.6bNT$7.9b23.4x68.5x6.4x
Tue, 10 Jan 2023NT$492.7bNT$84.6bNT$7.9b21x62.5x5.8x
Thu, 08 Dec 2022NT$488.3bNT$84.6bNT$7.9b16.8x61.9x5.8x
Sat, 05 Nov 2022NT$411.1bNT$79.1bNT$4.3b17.1x94.5x5.2x
Mon, 03 Oct 2022NT$431.0bNT$78.9bNT$4.3b17.5x99.6x5.5x
Wed, 31 Aug 2022NT$475.4bNT$78.9bNT$4.3b18.8x109.9x6x
Fri, 29 Jul 2022NT$394.0bNT$76.7bNT$4.4b21.6x88.7x5.1x
Sun, 26 Jun 2022NT$402.9bNT$76.8bNT$4.4b21.6x92.2x5.2x
Tue, 24 May 2022NT$378.8bNT$76.8bNT$4.4b19.7x86.7x4.9x
Thu, 21 Apr 2022NT$415.1bNT$76.5bNT$6.5b22x63.6x5.4x
Sat, 19 Mar 2022NT$390.8bNT$77.3bNT$8.1b20.3x48x5.1x
Mon, 14 Feb 2022NT$391.0bNT$76.7bNT$8.5b19.2x46.2x5.1x
Wed, 12 Jan 2022NT$380.1bNT$76.7bNT$8.5b18.1x44.9x5x
Fri, 10 Dec 2021NT$392.5bNT$76.7bNT$8.5b17.2x46.4x5.1x
Sun, 07 Nov 2021NT$366.4bNT$76.0bNT$10.5b17.6x35x4.8x
Tue, 05 Oct 2021NT$341.3bNT$76.0bNT$10.7b18x31.8x4.5x
Thu, 02 Sep 2021NT$350.9bNT$76.0bNT$10.7b19.2x32.7x4.6x
Sat, 31 Jul 2021NT$358.4bNT$76.0bNT$10.7b21.4x33.4x4.7x
Price to Earnings Ratio

33.4x


Total Market Cap: NT$358.4bTotal Earnings: NT$10.7bTotal Revenue: NT$76.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 66x202220232024
Current Industry PE
  • Investors are optimistic on the Taiwanese Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 101x which is higher than its 3-year average PE of 65.9x.
  • The 3-year average PS ratio of 5.6x is lower than the industry's current PS ratio of 6.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 14% per year over the last three years.
  • Meanwhile revenues for these companies have grown 9.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Taiwanese Pharma compare with similar industries?

TW Market-4.61%
Healthcare-0.93%
Pharma-1.64%
Pharma-1.64%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4743 Oneness BiotechNT$185.0015.6%
+NT$11.4b
-10.4%PS929.8x
3705 YungShin Global HoldingNT$54.605.2%
+NT$719.2m
23.7%PE15.8x
1720 Standard Chemical & PharmaceuticalNT$77.404.6%
+NT$607.6m
16.2%PE15.8x
6932 Mercury BiopharmaceuticalNT$15.806.4%
+NT$395.2m
-29.1%PS6362.2x
6586 CHO PharmaNT$65.402.3%
+NT$321.0m
-16.5%PB4.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4114

NT$40.50

Synmosa Biopharma

7D

1.4%

1Y

0.7%

1701

NT$22.55

China Chemical & Pharmaceutical

7D

1.3%

1Y

-7.8%

6785

NT$197.50

Alar Pharmaceuticals

7D

-6.2%

1Y

45.8%

4743

NT$185.00

Oneness Biotech

7D

15.6%

1Y

-10.4%

6535

NT$205.00

Lumosa Therapeutics

7D

-1.0%

1Y

232.3%

6634

NT$73.00

Sinew Pharma

7D

1.7%

1Y

3.8%

6620

NT$95.90

Handa Pharmaceuticals

7D

-6.9%

1Y

-41.0%

4123

NT$52.80

Center Laboratories

7D

-5.9%

1Y

-8.5%

6919

NT$602.00

Caliway Biopharmaceuticals

7D

-13.6%

1Y

255.7%

6586

NT$65.40

CHO Pharma

7D

2.3%

1Y

-16.5%

6932

NT$15.80

Mercury Biopharmaceutical

7D

6.4%

1Y

-29.1%

6838

NT$50.90

Formosa Pharmaceuticals

7D

-7.6%

1Y

-10.1%